Product Information

OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by Rising Pharma Holdings Inc., priced at $2.9968 per ML under NDC 16571086125. Its NADAC has been published 52 times since Aug 27, 2025.

FDA first approved this application on Jun 16, 2020.

OLOPATADINE HCL 0.2% EYE DROP

olopatadine hydrochloride
$2.9968per ML
OTC

Strength

2 mg/mL

NDC

16571086125

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

OLOPATADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204620

FDA Approved

6/16/2020

On Market Since

5/1/2025

Pharmacological Classes

Decreased Histamine Release
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
Histamine-1 Receptor Inhibitor
Mast Cell Stabilizer

Price Statistics

The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 52 times since Aug 27, 2025, and over the history we have for it it has declined 17.2%. The table below summarizes its recorded NADAC range and movement.

Current price$2.9968 per ML
All-time high$3.6822 (Oct 15, 2025)
All-time low$2.9954 (Jun 17, 2026)
52-week high$3.6822
52-week low$2.9954
Median price$3.2689
Average price$3.3240
Largest weekly change-5.1% (Dec 17, 2025)
Weeks tracked52
Tracking sinceAug 27, 2025

Price History

1W

+0.0%

1M

+0.0%

3M

-3.2%

6M

-8.3%

1Y

N/A

3Y

N/A

5Y

N/A

All

-17.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the olopatadine hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by Rising Pharma Holdings Inc., is $2.9968 per ML (NDC 16571086125), effective Aug 19, 2026.

How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?

Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 17.2%. It has been tracked across 52 weekly CMS publications since Aug 27, 2025.

What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?

Since Aug 27, 2025, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $2.9954 (Jun 17, 2026) to a high of $3.6822 (Oct 15, 2025), with a median of $3.2689 per ML.

Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?

No other NADAC-published product currently shares the active ingredient and strength of OLOPATADINE HCL 0.2% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OLOPATADINE HCL 0.2% EYE DROP?

OLOPATADINE HCL 0.2% EYE DROP (NDC 16571086125) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.